Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram

Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagu...

Full description

Saved in:
Bibliographic Details
Published inThrombosis and haemostasis Vol. 102; no. 5; p. 936
Main Authors Machlus, Kellie R, Colby, Emily A, Wu, Jogin R, Koch, Gary G, Key, Nigel S, Wolberg, Alisa S
Format Journal Article
LanguageEnglish
Published Germany 01.11.2009
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and platelet-rich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. The relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX, VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels.
AbstractList Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and platelet-rich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. The relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX, VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels.
Author Machlus, Kellie R
Wolberg, Alisa S
Wu, Jogin R
Key, Nigel S
Colby, Emily A
Koch, Gary G
Author_xml – sequence: 1
  givenname: Kellie R
  surname: Machlus
  fullname: Machlus, Kellie R
  organization: Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA
– sequence: 2
  givenname: Emily A
  surname: Colby
  fullname: Colby, Emily A
– sequence: 3
  givenname: Jogin R
  surname: Wu
  fullname: Wu, Jogin R
– sequence: 4
  givenname: Gary G
  surname: Koch
  fullname: Koch, Gary G
– sequence: 5
  givenname: Nigel S
  surname: Key
  fullname: Key, Nigel S
– sequence: 6
  givenname: Alisa S
  surname: Wolberg
  fullname: Wolberg, Alisa S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19888532$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtKAzEUhoMoWqs715IHcDSXaSZZSqlWKLip4K7kclIDM0nJZASfwZd2rOPqP3z8FziX6DSmCAjdUHJPqSAP2zVRFeEVoZKcoBlbiKYSUr2fowuqpJQLzmboe-U92NLj5HEJfT8A9tqWlO9w-cipM6lLbmhDxDo6DC186gIO2zaVEuJ-MuORQzuWxCk1-vcQIesSRhZ-MWCr22DyMa-HkrrjNa3ss-6u0JnXbQ_Xk87R29Nqu1xXm9fnl-XjprKSklIpqgUBq-rGEmsba0xtHeHgRE1ZrShnRrqmtoY6IiinUjjNlKyNAGK48GyObv96D4PpwO0OOXQ6f-3-v8J-AJcnZIM
CitedBy_id crossref_primary_10_1016_j_thromres_2021_01_012
crossref_primary_10_1016_j_jtha_2023_03_024
crossref_primary_10_1111_bjh_13641
crossref_primary_10_1186_s41983_021_00275_7
crossref_primary_10_1016_j_thromres_2011_04_009
crossref_primary_10_1160_TH12_05_0355
crossref_primary_10_1309_AJCPC5C4AGFRDKMX
crossref_primary_10_1160_TH12_07_0529
crossref_primary_10_1074_jbc_M114_550566
crossref_primary_10_1097_MBC_0000000000000390
crossref_primary_10_1016_j_saa_2021_120250
crossref_primary_10_1016_j_bpj_2018_11_009
crossref_primary_10_1016_j_thromres_2014_02_002
crossref_primary_10_1111_jth_14744
crossref_primary_10_1161_ATVBAHA_117_309794
crossref_primary_10_1186_s12959_021_00335_1
crossref_primary_10_1111_jth_12600
crossref_primary_10_1089_ten_teb_2013_0709
crossref_primary_10_1111_j_1538_7836_2010_03825_x
crossref_primary_10_1111_jth_14581
crossref_primary_10_1016_j_thromres_2016_05_018
crossref_primary_10_3390_jcm10153401
crossref_primary_10_1038_nrdp_2015_6
crossref_primary_10_1111_j_1365_2141_2012_09134_x
crossref_primary_10_1097_ALN_0000000000000540
crossref_primary_10_1182_blood_2011_06_362814
crossref_primary_10_1111_ijlh_12293
crossref_primary_10_1016_j_thromres_2016_01_027
crossref_primary_10_1080_00914037_2024_2376247
crossref_primary_10_1182_blood_2010_11_316885
crossref_primary_10_1182_bloodadvances_2020003968
crossref_primary_10_1093_toxsci_kfu071
crossref_primary_10_1002_rth2_12310
crossref_primary_10_25557_0031_2991_2017_03_63_68
crossref_primary_10_1007_s12288_019_01092_y
crossref_primary_10_1093_humrep_det092
crossref_primary_10_1016_j_thromres_2020_07_053
crossref_primary_10_1007_s12185_022_03528_0
crossref_primary_10_1016_j_thromres_2016_09_024
crossref_primary_10_1016_j_rpth_2024_102636
crossref_primary_10_1213_ANE_0b013e31823a088c
crossref_primary_10_1016_j_cca_2014_12_020
crossref_primary_10_1080_00365513_2018_1427280
crossref_primary_10_5482_HAMO_16_09_0034
crossref_primary_10_1097_MBC_0000000000001148
crossref_primary_10_1161_ATVBAHA_112_250332
crossref_primary_10_1016_j_thromres_2010_09_002
crossref_primary_10_1016_j_thromres_2010_10_017
crossref_primary_10_1111_vox_12420
crossref_primary_10_1111_j_1365_2516_2010_02253_x
crossref_primary_10_1371_journal_pone_0124448
crossref_primary_10_1111_jth_12707
crossref_primary_10_1182_blood_2009_06_228940
crossref_primary_10_1016_j_thromres_2019_04_033
crossref_primary_10_1080_16078454_2022_2043573
crossref_primary_10_1016_j_thromres_2015_04_020
crossref_primary_10_1097_EJA_0000000000000322
crossref_primary_10_1007_s11239_019_01894_x
crossref_primary_10_1161_ATVBAHA_110_221721
crossref_primary_10_1161_ATVBAHA_113_301607
crossref_primary_10_3390_jcm9103077
crossref_primary_10_5482_HAMO_14_08_0033
crossref_primary_10_1016_j_bja_2019_02_012
crossref_primary_10_3899_jrheum_130200
crossref_primary_10_1111_hae_13157
crossref_primary_10_1111_jth_15270
crossref_primary_10_1213_ANE_0000000000001188
crossref_primary_10_1002_rth2_12611
crossref_primary_10_1002_rth2_12499
crossref_primary_10_1002_rth2_12332
crossref_primary_10_1002_rth2_12497
crossref_primary_10_1016_j_rpth_2024_102337
crossref_primary_10_1016_j_rpth_2023_102197
crossref_primary_10_1016_j_transci_2020_102852
crossref_primary_10_1111_j_1423_0410_2011_01562_x
crossref_primary_10_1016_j_cbpc_2017_07_005
crossref_primary_10_1080_21655979_2021_1981755
crossref_primary_10_1097_ALN_0000000000001760
crossref_primary_10_3389_fcell_2022_967482
crossref_primary_10_1111_jth_12997
crossref_primary_10_1016_j_thromres_2018_10_020
crossref_primary_10_1016_j_thromres_2012_07_017
crossref_primary_10_1111_jth_14011
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1160/TH09-03-0180
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2567-689X
ExternalDocumentID 19888532
Genre Research Support, U.S. Gov't, Non-P.H.S
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: K01 AR051021
– fundername: NIAMS NIH HHS
  grantid: K01AR051021
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-c810t-91a60ec947c0cc7cbb4cd03ed641249132b8d74cb1d0613186da2984b6e0b36f2
IngestDate Sat May 31 02:11:21 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c810t-91a60ec947c0cc7cbb4cd03ed641249132b8d74cb1d0613186da2984b6e0b36f2
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/2904819
PMID 19888532
ParticipantIDs pubmed_primary_19888532
PublicationCentury 2000
PublicationDate 2009-11-01
PublicationDateYYYYMMDD 2009-11-01
PublicationDate_xml – month: 11
  year: 2009
  text: 2009-11-01
  day: 01
PublicationDecade 2000
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Thrombosis and haemostasis
PublicationTitleAlternate Thromb Haemost
PublicationYear 2009
Score 2.2898161
Snippet Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in...
SourceID pubmed
SourceType Index Database
StartPage 936
SubjectTerms Adult
Automation
Blood Coagulation Factors - physiology
Blood Coagulation Tests
Calibration
Coumarins - analysis
Female
Fluorometry - instrumentation
Fluorometry - methods
Humans
Male
Middle Aged
Oligopeptides - analysis
Plasma
Platelet-Rich Plasma
Thrombin - biosynthesis
Thrombomodulin - physiology
Thromboplastin - physiology
Time Factors
Young Adult
Title Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
URI https://www.ncbi.nlm.nih.gov/pubmed/19888532
Volume 102
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELa2cOGCispfC5UP3CCQxI6THFG1dFW0iMNW6q3yb1spWVdq9sIr8DC8IjN2sklbQMAlimxnHXm-tWcm38wQ8oZJJZVmWWJr5xJuU5Yo7lRSSMll7kylHQYKL7-IxSk_OSvOZrMfE9bSplPv9bdfxpX8j1ShDeSKUbL_INntj0ID3IN84QoShutfyXg-kjG6sIB9-RxcN6x_0CrfehO45ugfx1ByiRqmbnykO8fhbxtkDvXfDfApGH8R0lFPmZAgTDSt8Xm56Xwb7vpZkOI1VXNXsRmTneDEl9K2HtTQm6utBr-U-rLZ3MTQoAYU4ZG5eOSbmO5zHnwvoyNhE939F_BC28GffaxldYzsv-NbPoy6D-YLR1DY60DxKhNRhaq648ac5hMEFpNtto5JU-5v_wL5kqsFfvBBmlgsEjVBwnUboJDVYPgX0bH65947ybiHrh2yA2YJ1ln9uhzCKUT6YTpzSEcbR98xWYLqstolj3ubg36MAHpCZna9R7734KHe0QgeGtHwjt6GDgUJ0gE6dIBOP5hG6FC_pgN06AgdeoXNlo7QoVvo0Al0npLTT_PV0SLpK3MkusrSDk5IKVKra17qVOtSK8W1SZk1IhQzz1iuKlNyrTKD-mJWCSPzuuJK2FQx4fJn5MHar-0LQg2DI6Uuq8rIjBeOqUxz5pgxBeNFyfKX5Hlcu_PrmH7lfFjV_d_2HJBHI8pekYcO_u_2NSiPnToMIvsJo7N4zA
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+tissue+factor%2C+thrombomodulin+and+elevated+clotting+factor+levels+on+thrombin+generation+in+the+calibrated+automated+thrombogram&rft.jtitle=Thrombosis+and+haemostasis&rft.au=Machlus%2C+Kellie+R&rft.au=Colby%2C+Emily+A&rft.au=Wu%2C+Jogin+R&rft.au=Koch%2C+Gary+G&rft.date=2009-11-01&rft.eissn=2567-689X&rft.volume=102&rft.issue=5&rft.spage=936&rft_id=info:doi/10.1160%2FTH09-03-0180&rft_id=info%3Apmid%2F19888532&rft_id=info%3Apmid%2F19888532&rft.externalDocID=19888532